Skip to main content

Table 2 Interventions – key parameter values

From: Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia

Intervention

Annual cost of intervention (£, 2015)

Incremental utility associated with intervention (QALY)

Relative risk of developing T2DM

Pragmatic lifestyle programme

Yr 1: £203.44

Yr 2: £80.02

0.0189

[Beta distribution, SE: 0.001]

During intervention: IFG: 0.74/IGT: 0.74/HbA1c: 0.74

[Lognormal distribution, SE: 0.11]

Intensive lifestyle programme

Yr 1: £1225

Yr 2: £689

Yr 3: £671

0.0189

[Beta distribution, SE: 0.001]

During intervention: IFG: 0.63/IGT: 0.55/HbA1c: 0.71

[Lognormal distribution, SE: 0.10 (IFG), 0.07 (IGT), 0.10 (HbA1c)]

Up to 7 years post- intervention: IFG: 0.80/IGT: 0.80/HbA1c: 0.71

[Lognormal distribution, SE: 0.06 (IFG), 0.06 (IGT), 0.10 (HbA1c)]

Metformin

£124.25

0.0031

[Beta distribution, SE: 0.002]

IFG: 0.82/IGT: 0.82/HbA1c: 0.62

[Lognormal distribution, SE: 0.05(IGT), 0.05 (IFG), 0.10 (HbA1c)]

  1. Parametric form and standard error of distribution used in probabilistic sensitivity analysis in italics
  2. Sources: Intervention costs (calculated – see Additional file 1: Appendix 2), incremental utilities [32], relative risks [8, 12, 15, 20, 21]